These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2864975

  • 1. Muscarinic receptors discriminated by pirenzepine are involved in the regulation of neurotransmitter release in rat nucleus accumbens.
    de Belleroche J, Gardiner IM.
    Br J Pharmacol; 1985 Oct; 86(2):505-8. PubMed ID: 2864975
    [Abstract] [Full Text] [Related]

  • 2. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J, Chung YC, Li Z, Dai J, Meltzer HY.
    Brain Res; 2002 Dec 20; 958(1):176-84. PubMed ID: 12468043
    [Abstract] [Full Text] [Related]

  • 3. Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release.
    de Belleroche JS, Gardiner IM.
    Br J Pharmacol; 1982 Feb 20; 75(2):359-65. PubMed ID: 7186823
    [Abstract] [Full Text] [Related]

  • 4. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP, Heath I, Hendrix JC, Shannon HE.
    J Pharmacol Exp Ther; 1993 Oct 20; 267(1):16-24. PubMed ID: 7901390
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T, Boselli C.
    J Pharmacol Exp Ther; 1989 Sep 20; 250(3):944-52. PubMed ID: 2778720
    [Abstract] [Full Text] [Related]

  • 6. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens.
    De Belleroche J, Kilpatrick IC, Birdsall NJ, Hulme EC.
    Brain Res; 1982 Feb 25; 234(2):327-37. PubMed ID: 7059834
    [Abstract] [Full Text] [Related]

  • 7. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE, Ramkumar V, Lai WS.
    J Pharmacol Exp Ther; 1986 Aug 25; 238(2):554-63. PubMed ID: 3755473
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK, Cubeddu LX.
    J Pharmacol Exp Ther; 1987 Jan 25; 240(1):203-15. PubMed ID: 3806384
    [Abstract] [Full Text] [Related]

  • 9. Muscarine receptor-mediated modulation of [3H]dopamine and [14C]acetylcholine release from rat neostriatal slices: selective antagonism by gallamine but not pirenzepine.
    Schoffelmeer AN, Van Vliet BJ, Wardeh G, Mulder AH.
    Eur J Pharmacol; 1986 Sep 09; 128(3):291-4. PubMed ID: 3792444
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.
    Xu M, Mizobe F, Yamamoto T, Kato T.
    Brain Res; 1989 Aug 28; 495(2):232-42. PubMed ID: 2765928
    [Abstract] [Full Text] [Related]

  • 11. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
    Wess J, Lambrecht G, Mutschler E, Brann MR, Dörje F.
    Br J Pharmacol; 1991 Jan 28; 102(1):246-50. PubMed ID: 2043926
    [Abstract] [Full Text] [Related]

  • 12. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
    Moss S, Sharott A, Goodhead LH, Mitchell SN.
    Eur J Pharmacol; 2003 Jan 24; 460(2-3):117-25. PubMed ID: 12559371
    [Abstract] [Full Text] [Related]

  • 13. Muscarinic receptor blockade increases basal acetylcholine release from striatal slices.
    Dolezal V, Wecker L.
    J Pharmacol Exp Ther; 1990 Feb 24; 252(2):739-43. PubMed ID: 2313598
    [Abstract] [Full Text] [Related]

  • 14. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Mar 24; 232(3):608-16. PubMed ID: 2579230
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1985 Jun 24; 233(3):707-14. PubMed ID: 3839264
    [Abstract] [Full Text] [Related]

  • 16. Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats.
    Jung M, Perio A, Terranova JP, Worms P, Biziere K.
    Eur J Pharmacol; 1987 Jul 02; 139(1):111-6. PubMed ID: 3653237
    [Abstract] [Full Text] [Related]

  • 17. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD, Mash DC.
    J Pharmacol Exp Ther; 1989 Aug 02; 250(2):573-81. PubMed ID: 2760841
    [Abstract] [Full Text] [Related]

  • 18. Selective antagonism by pirenzepine and N-methyl-scopolamine on muscarinic receptor subtypes of the rat vas deferens.
    Miranda HF, Silva WI, Wolstenholme WW, Cuevas N.
    Gen Pharmacol; 1988 Aug 02; 19(3):417-20. PubMed ID: 3417103
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Age-related differences in the effects of some muscarinic agents on acetylcholine release from rat neostriatal slices.
    Lee HJ, Cozzi NV, Weiler MH.
    J Pharmacol Exp Ther; 1991 Aug 02; 258(2):496-501. PubMed ID: 1865353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.